Cargando…
Inhibition of miR-378a-3p by Inflammation Enhances IL-33 Levels: A Novel Mechanism of Alarmin Modulation in Ulcerative Colitis
Ulcerative colitis (UC) is an inflammatory bowel disease (IBD) characterized by mucosa damage associated with an uncontrolled inflammatory response. This immunological impairment leads to altered inflammatory mediators such as IL-33, which is shown to increase in the mucosa of active UC (aUC) patien...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6879552/ https://www.ncbi.nlm.nih.gov/pubmed/31824476 http://dx.doi.org/10.3389/fimmu.2019.02449 |
_version_ | 1783473623726555136 |
---|---|
author | Dubois-Camacho, Karen Diaz-Jimenez, David De la Fuente, Marjorie Quera, Rodrigo Simian, Daniela Martínez, Maripaz Landskron, Glauben Olivares-Morales, Mauricio Cidlowski, John A. Xu, Xiaojiang Gao, Guangping Xie, Jun Chnaiderman, Jonás Soto-Rifo, Ricardo González, María-Julieta Calixto, Andrea Hermoso, Marcela A. |
author_facet | Dubois-Camacho, Karen Diaz-Jimenez, David De la Fuente, Marjorie Quera, Rodrigo Simian, Daniela Martínez, Maripaz Landskron, Glauben Olivares-Morales, Mauricio Cidlowski, John A. Xu, Xiaojiang Gao, Guangping Xie, Jun Chnaiderman, Jonás Soto-Rifo, Ricardo González, María-Julieta Calixto, Andrea Hermoso, Marcela A. |
author_sort | Dubois-Camacho, Karen |
collection | PubMed |
description | Ulcerative colitis (UC) is an inflammatory bowel disease (IBD) characterized by mucosa damage associated with an uncontrolled inflammatory response. This immunological impairment leads to altered inflammatory mediators such as IL-33, which is shown to increase in the mucosa of active UC (aUC) patients. MicroRNAs present a distorted feature in inflamed colonic mucosa and are potential IL-33 regulating candidates in UC. Therefore, we studied the microRNA and mRNA profiles in inflamed colonic samples of UC patients, evaluating the effect of a microRNA (selected by in silico analysis and its expression in UC patients), on IL-33 under inflammatory conditions. We found that inflamed mucosa (n = 8) showed increased expression of 40 microRNAs and 2,120 mRNAs, while 49 microRNAs and 1,734 mRNAs were decreased, as determined by microarrays. In particular, IL-33 mRNA showed a 3.8-fold increase and eight members of a microRNA family (miR-378), which targets IL-33 mRNA in the 3′UTR, were decreased (−3.9 to −3.0 times). We selected three members of the miR-378 family (miR-378a-3p, miR-422a, and miR-378c) according to background information and interaction energy analysis, for further correlation analyses with IL-33 expression through qPCR and ELISA, respectively. We determined that aUC (n = 24) showed high IL-33 levels, and decreased expression of miR-378a-3p and miR-422a compared to inactive UC (n = 10) and controls (n = 6). Moreover, both microRNAs were inversely correlated with IL-33 expression, while miR-378c does not show a significant difference. To evaluate the effect of TNFα on the studied microRNAs, aUC patients with anti-TNF therapy were compared to aUC receiving other treatments. The levels of miR-378a-3p and miR-378c were higher in aUC patients with anti-TNF. Based on these findings, we selected miR-378a-3p to exploring the molecular mechanism involved by in vitro assays, showing that over-expression of miR-378a-3p decreased the levels of an IL-33 target sequence β-gal-reporter gene in HEK293 cells. Stable miR-378a-3p over-expression/inhibition inversely modulated IL-33 content and altered viability of HT-29 cells. Additionally, in an inflammatory context, TNFα decreased miR-378a-3p levels in HT-29 cells enhancing IL-33 expression. Together, our results propose a regulatory mechanism of IL-33 expression exerted by miR-378a-3p in an inflammatory environment, contributing to the understanding of UC pathogenesis. |
format | Online Article Text |
id | pubmed-6879552 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-68795522019-12-10 Inhibition of miR-378a-3p by Inflammation Enhances IL-33 Levels: A Novel Mechanism of Alarmin Modulation in Ulcerative Colitis Dubois-Camacho, Karen Diaz-Jimenez, David De la Fuente, Marjorie Quera, Rodrigo Simian, Daniela Martínez, Maripaz Landskron, Glauben Olivares-Morales, Mauricio Cidlowski, John A. Xu, Xiaojiang Gao, Guangping Xie, Jun Chnaiderman, Jonás Soto-Rifo, Ricardo González, María-Julieta Calixto, Andrea Hermoso, Marcela A. Front Immunol Immunology Ulcerative colitis (UC) is an inflammatory bowel disease (IBD) characterized by mucosa damage associated with an uncontrolled inflammatory response. This immunological impairment leads to altered inflammatory mediators such as IL-33, which is shown to increase in the mucosa of active UC (aUC) patients. MicroRNAs present a distorted feature in inflamed colonic mucosa and are potential IL-33 regulating candidates in UC. Therefore, we studied the microRNA and mRNA profiles in inflamed colonic samples of UC patients, evaluating the effect of a microRNA (selected by in silico analysis and its expression in UC patients), on IL-33 under inflammatory conditions. We found that inflamed mucosa (n = 8) showed increased expression of 40 microRNAs and 2,120 mRNAs, while 49 microRNAs and 1,734 mRNAs were decreased, as determined by microarrays. In particular, IL-33 mRNA showed a 3.8-fold increase and eight members of a microRNA family (miR-378), which targets IL-33 mRNA in the 3′UTR, were decreased (−3.9 to −3.0 times). We selected three members of the miR-378 family (miR-378a-3p, miR-422a, and miR-378c) according to background information and interaction energy analysis, for further correlation analyses with IL-33 expression through qPCR and ELISA, respectively. We determined that aUC (n = 24) showed high IL-33 levels, and decreased expression of miR-378a-3p and miR-422a compared to inactive UC (n = 10) and controls (n = 6). Moreover, both microRNAs were inversely correlated with IL-33 expression, while miR-378c does not show a significant difference. To evaluate the effect of TNFα on the studied microRNAs, aUC patients with anti-TNF therapy were compared to aUC receiving other treatments. The levels of miR-378a-3p and miR-378c were higher in aUC patients with anti-TNF. Based on these findings, we selected miR-378a-3p to exploring the molecular mechanism involved by in vitro assays, showing that over-expression of miR-378a-3p decreased the levels of an IL-33 target sequence β-gal-reporter gene in HEK293 cells. Stable miR-378a-3p over-expression/inhibition inversely modulated IL-33 content and altered viability of HT-29 cells. Additionally, in an inflammatory context, TNFα decreased miR-378a-3p levels in HT-29 cells enhancing IL-33 expression. Together, our results propose a regulatory mechanism of IL-33 expression exerted by miR-378a-3p in an inflammatory environment, contributing to the understanding of UC pathogenesis. Frontiers Media S.A. 2019-11-20 /pmc/articles/PMC6879552/ /pubmed/31824476 http://dx.doi.org/10.3389/fimmu.2019.02449 Text en Copyright © 2019 Dubois-Camacho, Diaz-Jimenez, De la Fuente, Quera, Simian, Martínez, Landskron, Olivares-Morales, Cidlowski, Xu, Gao, Xie, Chnaiderman, Soto-Rifo, González, Calixto and Hermoso. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Dubois-Camacho, Karen Diaz-Jimenez, David De la Fuente, Marjorie Quera, Rodrigo Simian, Daniela Martínez, Maripaz Landskron, Glauben Olivares-Morales, Mauricio Cidlowski, John A. Xu, Xiaojiang Gao, Guangping Xie, Jun Chnaiderman, Jonás Soto-Rifo, Ricardo González, María-Julieta Calixto, Andrea Hermoso, Marcela A. Inhibition of miR-378a-3p by Inflammation Enhances IL-33 Levels: A Novel Mechanism of Alarmin Modulation in Ulcerative Colitis |
title | Inhibition of miR-378a-3p by Inflammation Enhances IL-33 Levels: A Novel Mechanism of Alarmin Modulation in Ulcerative Colitis |
title_full | Inhibition of miR-378a-3p by Inflammation Enhances IL-33 Levels: A Novel Mechanism of Alarmin Modulation in Ulcerative Colitis |
title_fullStr | Inhibition of miR-378a-3p by Inflammation Enhances IL-33 Levels: A Novel Mechanism of Alarmin Modulation in Ulcerative Colitis |
title_full_unstemmed | Inhibition of miR-378a-3p by Inflammation Enhances IL-33 Levels: A Novel Mechanism of Alarmin Modulation in Ulcerative Colitis |
title_short | Inhibition of miR-378a-3p by Inflammation Enhances IL-33 Levels: A Novel Mechanism of Alarmin Modulation in Ulcerative Colitis |
title_sort | inhibition of mir-378a-3p by inflammation enhances il-33 levels: a novel mechanism of alarmin modulation in ulcerative colitis |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6879552/ https://www.ncbi.nlm.nih.gov/pubmed/31824476 http://dx.doi.org/10.3389/fimmu.2019.02449 |
work_keys_str_mv | AT duboiscamachokaren inhibitionofmir378a3pbyinflammationenhancesil33levelsanovelmechanismofalarminmodulationinulcerativecolitis AT diazjimenezdavid inhibitionofmir378a3pbyinflammationenhancesil33levelsanovelmechanismofalarminmodulationinulcerativecolitis AT delafuentemarjorie inhibitionofmir378a3pbyinflammationenhancesil33levelsanovelmechanismofalarminmodulationinulcerativecolitis AT querarodrigo inhibitionofmir378a3pbyinflammationenhancesil33levelsanovelmechanismofalarminmodulationinulcerativecolitis AT simiandaniela inhibitionofmir378a3pbyinflammationenhancesil33levelsanovelmechanismofalarminmodulationinulcerativecolitis AT martinezmaripaz inhibitionofmir378a3pbyinflammationenhancesil33levelsanovelmechanismofalarminmodulationinulcerativecolitis AT landskronglauben inhibitionofmir378a3pbyinflammationenhancesil33levelsanovelmechanismofalarminmodulationinulcerativecolitis AT olivaresmoralesmauricio inhibitionofmir378a3pbyinflammationenhancesil33levelsanovelmechanismofalarminmodulationinulcerativecolitis AT cidlowskijohna inhibitionofmir378a3pbyinflammationenhancesil33levelsanovelmechanismofalarminmodulationinulcerativecolitis AT xuxiaojiang inhibitionofmir378a3pbyinflammationenhancesil33levelsanovelmechanismofalarminmodulationinulcerativecolitis AT gaoguangping inhibitionofmir378a3pbyinflammationenhancesil33levelsanovelmechanismofalarminmodulationinulcerativecolitis AT xiejun inhibitionofmir378a3pbyinflammationenhancesil33levelsanovelmechanismofalarminmodulationinulcerativecolitis AT chnaidermanjonas inhibitionofmir378a3pbyinflammationenhancesil33levelsanovelmechanismofalarminmodulationinulcerativecolitis AT sotoriforicardo inhibitionofmir378a3pbyinflammationenhancesil33levelsanovelmechanismofalarminmodulationinulcerativecolitis AT gonzalezmariajulieta inhibitionofmir378a3pbyinflammationenhancesil33levelsanovelmechanismofalarminmodulationinulcerativecolitis AT calixtoandrea inhibitionofmir378a3pbyinflammationenhancesil33levelsanovelmechanismofalarminmodulationinulcerativecolitis AT hermosomarcelaa inhibitionofmir378a3pbyinflammationenhancesil33levelsanovelmechanismofalarminmodulationinulcerativecolitis |